Brooklyn, New York Clinical Trials

A listing of Brooklyn, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 381 clinical trials
Mobile Attentional Bias Modification Training in Pediatric MS

This study will examine the feasibility of using a mobile ABMT application as a treatment modality in the Pediatric Multiple Sclerosis population. Participants will be asked to undergo one hour-long baseline evaluation, followed by at-home ABMT application sessions. Subjects will complete online REDCap or MyCap surveys weekly and at the …

NYU Langone Health
 (3.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients

This Phase 1 single-dose, dose-escalation study is an open label trial evaluating the safety of CPI-006, a humanized monoclonal antibody targeting the CD73 cell-surface ectonucleotidase, as immunotherapy for stable hospitalized mild or moderately symptomatic COVID-19 patients.

acute respiratory syndrome (sars)
covid-19
nasal swab
SARS
nasopharyngeal swab
Icahn School of Medicine at Mount Sinai
 (7.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Personalized Second Chance Breast Conservation (PSCBC): A Two Center Prospective Phase II Clinical Study

The goal of the study is to investigate the feasibility of enabling a second chance for breast conservation in patients with in-breast recurrences after a previous lumpectomy and RT, investigators propose to test partial breast irradiation with the target volume encompassing the entire surgical bed with 1.0-1.5 cm margins.

systemic therapy
metastasis
breast carcinoma
carcinoma
radiotherapy to breast
Weill Cornell Medicine
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

Memorial Sloan Kettering Cancer Center
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
Families Children and Teachers Thriving Together

The current study examines the impact of ParentCorps in high-poverty district schools in New York City (NYC). The study is conducted within the context of the NYC Department of Education (DOE) Pre-K Thrive initiative. As part of this initiative, the Center for Early Childhood Health and Development (CEHD) at NYU …

cehd
inspire
NYU Langone Health
 (3.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
UAT Study

Bowen Test Study Overview

Formal Site
 (3.8 away) Contact site
  • 0 views
  • 09 May, 2025
  • +7 other locations
None

Memorial Sloan Kettering Cancer Center
 (5.1 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease  

The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).

alzheimer's disease
Weill Cornell Medicine
 (5.1 away)
  • 0 views
  • 09 May, 2025
  • +2 other locations
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System - INFINITE-US

Prospective, non-randomized, multicenter pre-market early feasibility study (EFS) to evaluate subjects treated with the BlueLeaf System for the treatment of symptomatic CVI of the lower extremity

NYU Langone Medical Center
 (3.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Dynamically Tailored Behavioral Interventions in Diabetes

In this project, the investigators will evaluate the efficacy of a novel approach to personalizing behavioral interventions for self-management of type 2 diabetes (T2DM) to individuals' behavioral and glycemic profiles discovered using computational learning and self-monitoring data. This study is a two-arm randomized controlled trial with n=280 participants recruited from …

self monitoring
behavior modification
Clinical Directors Network
 (4.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations